Well, the Clinical Trial Cops look to be getting Smart®-er [and you’ve just got to admire yankee ingenuity]. Smart® is a device that takes the "non" out of non-compliance. Your study medicine has a little additive. So you take your pill and push a button, and after 20-30 minutes, it alerts you to blow into […]
My interest in this article [restoring pharma I…] has a personal component. I’m not being coy when I say that I was stunned when Senator Grassley revealed what I would now call the Academic·Psychiatry·PHARMA·Alliance and all the corruption among, around, and in-between. I have figured out some of the reasons – medical school to internal […]
I want to say some things about this article later… Restoring the pharmaceutical industry’s reputation by Mark Kessel Nature Biotechnology 2014 32[10]:983–990. [full text on-line] … but first, here’s a graphic and table to ponder: Date Pharma Fine [$M] Infringement 02/2014 Endo 193 criminal and civil liabilities arising from Endo’s marketing of the prescription drug […]
"I venture to suggest that most practicing psychiatrists, if pressed, would choose to replace or discard any existing treatment or intervention save one: the power to impose a treatment or intervention." It’s the Coercion, Stupid! by David Cohen Note the list of people authorized to sign the Commitment form. In addition, the Georgia Advocacy Office […]
With the American Academy of Child and Adolescent Psychiatry meeting in San Diego right now, I’m having something of a remembrance of things past period. Of course there’s Paxil Study 329 which stands in my mind as a paradigm for an infamous era, along with a other less well known Clinical Trials suggesting that the […]
Senate Lawmaker Eyes Hearing on the Cost of Hepatitis C Treatments Pharmalot: WSJ By Ed Silverman October 20, 2013 Responding to the ongoing controversy over the prices for new hepatitis C treatments, U.S. Sen. Bernard Sanders [I-Vt.] will probably hold a hearing – possibly before the year ends – to examine how the cost is […]
Some things are just so sensible that they need no comment. Here’s one now: Finding Middle Ground Between Psychiatry and Anti-Psychiatry Mental health civil wars leave patients in desperate lurch Psychology Today: Saving Normal by Allen J. Frances, M.D. October 20, 2014 [full text on-line]
“APA has a role in shaping what future psychiatric practice looks like,” Schatzberg stated. “More needs to be done now if we are to have new treatments in the next decade for patients with psychiatric disorders.” Alan Schatzberg in APF Convenes Unique Pipeline Summit, April 2012 Pipeline and Innovation for Psychotropic Drugs Are Limited, Study […]
"We look forward to welcoming you to sunny San Diego for AACAP’s 61st Annual Meeting! Gabrielle Carlson, MD, AACAP’s Program Chair, welcomes you to San Diego from the USS Midway, the site of the Welcome Reception on Wednesday, October 22. All are invited to attend!" In the spirited video from the deck of the USS […]
Black Box Warning Should Remain on Chantix®: Panel WebMD October 17, 2014 A black box warning about suicide risks should remain on the anti-smoking drug Chantix® until it can be reevaluated using findings from thorough scientific studies, a U.S. Food and Drug Administration panel of experts said Thursday. Chantix® has carried the FDA’s strongest warning […]